Type 1 Diabetes Extension Study
(T1DES Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D).This observational study will:* follow participants to determine how long they continue to produce insulin, and* will also assess how changes in the immune system over time relate to the ability to produce insulin.This information could help design better therapies for type 1 diabetes in the future.
Who Is on the Research Team?
Linda A. DiMeglio, MD, MPH,MA
Principal Investigator
Riley Hospital for Children at Indiana University Health
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Evaluation
Participants undergo overall health assessments, blood and urine collections, and MMTTs for certain participants
Follow-up
Participants are monitored for safety and effectiveness after evaluation
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
Immune Tolerance Network (ITN)
Collaborator